Literature DB >> 29449721

Bi-allelic inactivating variants in the COCH gene cause autosomal recessive prelingual hearing impairment.

Sebastien P F JanssensdeVarebeke1, Guy Van Camp2, Nils Peeters2, Ellen Elinck2, Josine Widdershoven3, Tony Cox3, Kristof Deben3, Katrien Ketelslagers3, Tom Crins3, Wim Wuyts2.   

Abstract

Pathogenic variant in COCH are a known cause of DFNA9 autosomal dominant progressive hearing loss and vestibular dysfunction with adult onset. Hitherto, only dominant nonsynonymous variants and in-frame deletions with a presumed dominant negative or gain-of-function effect have been described. Here, we describe two brothers with congenital prelingual deafness and a homozygous nonsense c.292C>T(p.Arg98*) COCH variant, suggesting a loss-of-function effect. Vestibular dysfunction starting in the first decade was observed in the older patient. The heterozygous parents and sibling have normal hearing and vestibular function, except for the mother, who shows vestibular hyporeflexia and abnormal smooth pursuit tests, most likely due to concomitant disease. This is the first report of autosomal recessive inheritance of cochlea-vestibular dysfunction caused by a pathogenic variant in the COCH gene. An earlier onset of hearing impairment and vestibular dysfunction compared to the dominant hearing loss causing COCH variants is observed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29449721      PMCID: PMC5891501          DOI: 10.1038/s41431-017-0066-2

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  17 in total

1.  Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.

Authors:  Sherri M Jones; Nahid G Robertson; Shelly Given; Anne B S Giersch; M Charles Liberman; Cynthia C Morton
Journal:  Hear Res       Date:  2010-11-10       Impact factor: 3.208

2.  Vestibular deterioration precedes hearing deterioration in the P51S COCH mutation (DFNA9): an analysis in 74 mutation carriers.

Authors:  Anne M L C Bischoff; Patrick L M Huygen; Martijn H Kemperman; Ronald J E Pennings; Steven J H Bom; Wim I M Verhagen; Ronald J C Admiraal; Hannie Kremer; Cor W R J Cremers
Journal:  Otol Neurotol       Date:  2005-09       Impact factor: 2.311

3.  Detailed hearing and vestibular profiles in the patients with COCH mutations.

Authors:  Keita Tsukada; Aya Ichinose; Maiko Miyagawa; Kentaro Mori; Mitsuru Hattori; Shin-Ya Nishio; Yasushi Naito; Shin-Ichiro Kitajiri; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-16       Impact factor: 1.547

4.  Progressive cochleovestibular impairment caused by a point mutation in the COCH gene at DFNA9.

Authors:  S J Bom; M H Kemperman; Y J De Kok; P L Huygen; W I Verhagen; F P Cremers; C W Cremers
Journal:  Laryngoscope       Date:  1999-09       Impact factor: 3.325

5.  A novel COCH mutation associated with autosomal dominant nonsyndromic hearing loss disrupts the structural stability of the vWFA2 domain.

Authors:  Hyun-Ju Cho; Hong-Joon Park; Maria Trexler; Hanka Venselaar; Kyu Yup Lee; Nahid G Robertson; Jeong-In Baek; Beom Sik Kang; Cynthia C Morton; Gert Vriend; László Patthy; Un-Kyung Kim
Journal:  J Mol Med (Berl)       Date:  2012-05-19       Impact factor: 4.599

6.  Whole exome sequencing identifies a novel DFNA9 mutation, C162Y.

Authors:  J Gao; J Xue; Li Chen; X Ke; Y Qi; Y Liu
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

7.  Inner ear localization of mRNA and protein products of COCH, mutated in the sensorineural deafness and vestibular disorder, DFNA9.

Authors:  N G Robertson; B L Resendes; J S Lin; C Lee; J C Aster; J C Adams; C C Morton
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

8.  Targeted disruption of mouse Coch provides functional evidence that DFNA9 hearing loss is not a COCH haploinsufficiency disorder.

Authors:  Tomoko Makishima; Clara I Rodriguez; Nahid G Robertson; Cynthia C Morton; Colin L Stewart; Andrew J Griffith
Journal:  Hum Genet       Date:  2005-10-28       Impact factor: 4.132

9.  A novel frameshift variant of COCH supports the hypothesis that haploinsufficiency is not a cause of autosomal dominant nonsyndromic deafness 9.

Authors:  Masatsugu Masuda; Hideki Mutai; Yukiko Arimoto; Atsuko Nakano; Tatsuo Matsunaga
Journal:  Biochem Biophys Res Commun       Date:  2015-11-26       Impact factor: 3.575

10.  Focal sclerosis of semicircular canals with severe DFNA9 hearing impairment caused by a P51S COCH-mutation: is there a link?

Authors:  Sebastien Pierre Janssens de Varebeke; Bruno Termote; Guy Van Camp; Paul J Govaerts; Steven Schepers; Tony Cox; Kristof Deben; Katrien Ketelslagers; Geert Souverijns
Journal:  Otol Neurotol       Date:  2014-07       Impact factor: 2.311

View more
  9 in total

Review 1.  Identification of autosomal recessive nonsyndromic hearing impairment genes through the study of consanguineous and non-consanguineous families: past, present, and future.

Authors:  Anushree Acharya; Isabelle Schrauwen; Suzanne M Leal
Journal:  Hum Genet       Date:  2021-07-22       Impact factor: 4.132

2.  COCH-related autosomal dominant nonsyndromic hearing loss: a phenotype-genotype study.

Authors:  Kyung Seok Oh; Daniel Walls; Richard J Smith; Jae Young Choi; Heon Yung Gee; Jinsei Jung; Sun Young Joo; Jung Ah Kim; Jee Eun Yoo; Young Ik Koh; Da Hye Kim; John Hoon Rim; Hye Ji Choi; Hye-Youn Kim; Seyoung Yu
Journal:  Hum Genet       Date:  2021-09-16       Impact factor: 5.881

Review 3.  Genetics of pediatric hearing loss: A functional perspective.

Authors:  Harmon Khela; Margaret A Kenna
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-05-02

4.  AON-based degradation of c.151C>T mutant COCH transcripts associated with dominantly inherited hearing impairment DFNA9.

Authors:  Erik de Vrieze; Jorge Cañas Martín; Jolien Peijnenborg; Aniek Martens; Jaap Oostrik; Simone van den Heuvel; Kornelia Neveling; Ronald Pennings; Hannie Kremer; Erwin van Wijk
Journal:  Mol Ther Nucleic Acids       Date:  2021-03-01       Impact factor: 8.886

5.  Cochlin Deficiency Protects Aged Mice from Noise-Induced Hearing Loss.

Authors:  Dorien Verdoodt; Noa Peeleman; Krystyna Szewczyk; Guy Van Camp; Peter Ponsaerts; Vincent Van Rompaey
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

Review 6.  Genotype-Phenotype Correlations of Pathogenic COCH Variants in DFNA9: A HuGE Systematic Review and Audiometric Meta-Analysis.

Authors:  Sybren M M Robijn; Jeroen J Smits; Kadriye Sezer; Patrick L M Huygen; Andy J Beynon; Erwin van Wijk; Hannie Kremer; Erik de Vrieze; Cornelis P Lanting; Ronald J E Pennings
Journal:  Biomolecules       Date:  2022-01-27

7.  Ciliopathy genes are required for apical secretion of Cochlin, an otolith crystallization factor.

Authors:  Eleni Leventea; Zhou Zhu; Xiaoming Fang; Yulia Nikolaeva; Eleanor Markham; Robert A Hirst; Fredericus J M van Eeden; Jarema J Malicki
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

8.  Genotype-phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9): Part I-A Cross-sectional Study of Hearing Function in 111 Carriers.

Authors:  Sebastien P F JanssensdeVarebeke; Julie Moyaert; Erik Fransen; Britt Bulen; Celine Neesen; Katrien Devroye; Raymond van de Berg; Ronald J E Pennings; Vedat Topsakal; Olivier Vanderveken; Guy Van Camp; Vincent Van Rompaey
Journal:  Ear Hear       Date:  2021 Nov-Dec 01       Impact factor: 3.570

9.  Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers.

Authors:  Sebastien P F JanssensdeVarebeke; Julie Moyaert; Erik Fransen; Britt Bulen; Celine Neesen; Katrien Devroye; Raymond van de Berg; Ronald J E Pennings; Vedat Topsakal; Olivier Vanderveken; Guy Van Camp; Vincent Van Rompaey
Journal:  Ear Hear       Date:  2021 Nov-Dec 01       Impact factor: 3.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.